The Primary Objective of This Study is to Determine Whether Positively Framed Information (PFI) on Side Effects, Compared to Negatively Framed and Extensive Information (NFI) Can Reduce the Number and Severity of Reported Adverse Events Caused by ADHD Medication in Children Aged 7 to 17 Years.

Launched by ST. ANTONIUS HOSPITAL · Jan 22, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring how different ways of sharing information about side effects may affect children taking medication for ADHD. Specifically, researchers want to see if giving positive and straightforward information (called Positively Framed Information or PFI) can help reduce side effects and improve satisfaction compared to providing detailed and negative information (Negatively Framed Information or NFI). The study will involve children aged 7 to 17 who have recently been diagnosed with ADHD and want to start medication.

Participants will be randomly assigned to receive either PFI or NFI about the side effects of the medication they will be taking. After four weeks, they will fill out a questionnaire to report any side effects they experienced and how severe they were. Parents will also provide feedback about how satisfied they were with the information given about these side effects. The goal is to find better ways to communicate potential side effects to help children stick with their treatment and improve their overall experience.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Children aged 7 to 17 years
• • Recently diagnosed with ADHD or ADD by a psychologist
• • Desire to start ADHD/ADD medication expressed by both the child and the parents
• Exclusion Criteria:
• • Previous use of stimulants
• • 1st or 2nd degree family member using stimulants for ADHD/ADD within the last two years